Expression of PSTPIP1 in Renal Cell Carcinoma and Its Prognostic Value
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.High expression of PSTPIP1 protein is linked to poor prognosis in clear cell renal cell carcinoma (ccRCC). This finding suggests PSTPIP1 may be a potential therapeutic target for treating ccRCC, a common kidney cancer.
Area Of Science
- Oncology
- Molecular Biology
- Immunology
Background
- Clear cell renal cell carcinoma (ccRCC) is the most prevalent kidney cancer subtype.
- Targeted therapies for ccRCC remain limited.
- PSTPIP1 is implicated in immune pathways and often overexpressed in tumors.
Purpose Of The Study
- To investigate the correlation between PSTPIP1 and ccRCC.
- To evaluate PSTPIP1 as a potential therapeutic target for ccRCC.
Main Methods
- Analysis of PSTPIP1 mRNA expression using multiple databases (Oncomine, TCGA, UALCAN, GSCA, GEPIA).
- Detection of PSTPIP1 protein via immunohistochemistry (IHC) in clinical samples.
- Statistical analyses (chi-square, univariate, multivariate) to assess PSTPIP1-ccRCC relationships.
- Gene co-expression and pathway enrichment analysis (TCGA, GSEA).
- Protein-protein interaction network construction.
Main Results
- PSTPIP1 mRNA and protein expression were significantly elevated in ccRCC tissues compared to normal renal tissues.
- PSTPIP1 levels correlated with tumor size, TNM stage, and PD-L1 status.
- Overexpression of PSTPIP1 was associated with reduced overall survival in ccRCC patients.
Conclusions
- High PSTPIP1 expression is a significant predictor of poor prognosis in ccRCC.
- PSTPIP1 represents a potential therapeutic target for ccRCC treatment.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
